Dr. Douglas N. Abrams

Assistant Professor
Departmentof Radiology
Health Sciences Centre
Section of Nuclear Medicine, PW160, C2, General Centre
Winnipeg, MB R3A 1R9 Canada

Phone: (204) 787-4062, Fax: (204) 787-2080
E-mail: Dabrams@exchange.hsc.mb.ca (Doug Abrams)

Publications

Su, Z.F., J.R. Ballinger, A.M. Rauth, D.N. Abrams & M.W. Billinghurst (2000). A novel amine-dioxime chelator for technetium-99m: synthesis and evaluation of 2-nitroimidazole-containing analogues as markers for hypoxic cells. Bioconjug Chem 11(5), 652-63. URL = 10995208

Abrams, D.N., I. Koslowsky & G. Matte (2000). Pharmaceutical interference with the [14C] carbon urea breath test for the detection of Helicobacter pylori infection. J Pharm Pharm Sci 3(2), 228-33. URL = 20451365

Leslie, W.D., C.R. Greenberg, D.N. Abrams & D. Hobson (1999). Clinical deficits in Huntington disease correlate with reduced striatal uptake on iodine-123 epidepride single-photon emission tomography. Eur J Nucl Med 26(11), 1458-64. URL = 20020064

Leslie, W.D., D.N. Abrams, C.R. Greenberg & D. Hobson (1996). Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging. J Nucl Med 37(10), 1589-91. URL = 97015639

Stern, S.S., W.D. Leslie, J.O. Dupont, A.E. Peterdy, M.W. Billinghurst & D.N. Abrams (1995). Hepatobiliary clearance of intravenous Tc-99m pertechnetate. Clin Nucl Med 20(11), 962-4. URL = 96146972

Leslie, W.D., D.N. Abrams & M.W. Billinghurst (1991). Elution characteristics of 99Tcm-labelled erythrocytes in relation to scintigraphic detection of gastrointestinal bleeding. Nucl Med Commun 12(11), 983-92. URL = 92093284

Billinghurst, M.W., D.N. Abrams & M.S. Lawson (1991). Stabilization of [99mTc]HMPAO--1. Ethanolic preparation. Int J Rad Appl Instrum [A] 42(7), 607-12. URL = 92120922

Billinghurst, M.W., D.N. Abrams & M.S. Lawson (1989). Chemical aspects of labeling sucralfate with 99mTcO4. J Nucl Med 30(4), 523-30. URL = 89293298

Billinghurst, M.W., D.N. Abrams & L. Light (1988). Interaction of some sterilizing filter materials with some technetium-99m radiopharmaceuticals. Int J Rad Appl Instrum [A] 39(12), 1255-8. URL = 89108806

Abrams, D.N., S.F. Man & A.A. Noujaim (1987). Evaluation of the lung uptake of iodine-131 HIPDM by the single-pass multiple indicator dilution technique in a rabbit model. J Nucl Med 28(4), 487-94. URL = 87197621

Abrams, D.N., Y.W. Lee, J.R. Mercer, E.E. Knaus & L.I. Wiebe (1986). Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabelled 1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)uracil and 1-(2'-chloro-2'-deoxy-beta-D-ribofuranosyl)uracil. Br J Radiol 59(699), 263-70. URL = 86132279

Lee, Y.W., D.N. Abrams, L.I. Wiebe & E.E. Knaus (1984). Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--V. 6-[36Cl]chlorouracil, 6-[82Br]bromouracil and 6-[123I]iodouracil. Int J Nucl Med Biol 11(3-4), 262-6. URL = 85156745 (no abstract available)

Abrams, D.N., E.E. Knaus, L.I. Wiebe, F. Helus & W. Maier-Borst (1981). Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--IV. 2'-123I-iodo-2'-deoxyuridine. Int J Appl Radiat Isot 32(2), 105-8. URL = 81140992 (no abstract available)

Abrams, D.N., E.E. Knaus & L.I. Wiebe (1979). Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--I. 6-[3H]-5-fluorouracil. Int J Nucl Med Biol 6(2), 97-101. URL = 80005810 (no abstract available)

Abrams, D.N., E.E. Knaus, B.C. Lentle & L.I. Wiebe (1979). Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--II. 6-[3H]-5-fluoro-2'-deoxyuridine. Int J Nucl Med Biol 6(2), 103-7. URL = 80005797 (no abstract available)

Return to the Radiology Home Page
Return to the University of Manitoba Home Page